In April 2020, British mobile-network operators reported fires at masts and abuse directed at engineers. Some damaged equipment did not carry 5G at all. An allegation about a new wireless technology had become a reason to attack the communications infrastructure people were using during a public-health emergency.
The allegation took several forms. Some accounts claimed that radio waves created or transmitted the coronavirus; others claimed that doctors were mistaking radiation effects for COVID-19. Other versions proposed that exposure weakened the immune system. These are different claims, but they were often presented as interchangeable explanations for the same outbreak.
The claim that 5G caused or spread COVID-19 fails as an account of infection. Questions about radiofrequency exposure can instead be tested in defined experiments and human studies, whose outcomes need to be interpreted on their own terms.
5G names a generation of mobile communications standards. It is not the name of a single frequency, power level or biological effect. Networks can use different frequency bands, and exposure varies with the transmitter, its operation and the position of the person exposed. The World Health Organization's February 2020 explanation describes both higher-frequency bands and antennas that direct signals toward devices.
Frequency describes how rapidly the electromagnetic field oscillates. Two signals at the same frequency can reach a person at different intensities; duration and absorption also affect exposure. A record of phone call-time therefore answers a different question from a street-level field reading. Neither quantity can be replaced by the label 5G.
Radiofrequency radiation is nonionizing. Its photons lack the energy to ionize atoms in the way that X-rays can. At sufficiently high intensity, however, radiofrequency energy can heat tissue. The National Cancer Institute's explanation distinguishes these processes. Nonionizing is a physical description, not a promise that any intensity of exposure is harmless.
Studies of biological effects ask whether a change after exposure is reproducible, harmful and relevant to the conditions people encounter. Finding a biological effect would leave the proposed connection to infection to be established.
The oxygen claim began with a real propagation effect. Oxygen absorbs electromagnetic energy strongly around some frequencies; engineers account for this when estimating how far a signal travels. A UK study of millimeter-wave propagation plots an absorption peak around 60 gigahertz. This describes energy being absorbed by gas. It does not mean the radio wave consumes breathable oxygen or removes it from blood.
A mobile signal can carry encoded information because a transmitter and receiver are built to use variations in an electromagnetic field. A virus is physical material with a genome and proteins. It reaches a susceptible host through biological routes of transmission and replicates using living cells. Broadcasting data does not transport viral particles from a mast into someone's lungs.
WHO made this point in an April 2020 myth sheet: viruses do not travel on mobile networks, and COVID-19 was spreading in countries without 5G networks. An explanation that required 5G failed where the infection spread without it.
A hypothesis about altered susceptibility would require a different investigation. It would need a defined exposure, an effect on susceptibility and evidence that the effect changed infections or illness. It would still require a source of the virus. Calling this an immune-system hypothesis does not provide those observations, and an animal cancer finding would not supply them either.
The origin of SARS-CoV-2 is another question again. The COVID-19 & The Lab Leak inquiry concerns how a biological agent first entered people. Rejection of a wireless-transmission story cannot decide between different biological origin histories. Nor does an unresolved origin make a transmitter a candidate merely because it was installed near an outbreak.
Exposure can be measured. In a report updated in April 2020, Ofcom described measurements at 22 UK locations near 5G-enabled base stations. The sites included busy transport and shopping areas. The highest combined measured level was about 1.5 percent of the applicable international reference level; the highest contribution in the band then used for 5G was 0.039 percent. Older mobile technologies contributed most of the measured total.
Those percentages compare measured fields with exposure reference levels; they are not estimates of the chance of developing a disease. They also describe different quantities. Calling the whole reading a 5G exposure would assign older signals to the new network. Calling a site “5G-enabled” does not mean every transmission there uses the new technology.
These measurements assessed conditions at particular places during an early rollout. They were not a national lifetime study, a measurement of every future traffic load or a test for cancer. Their value is that they replace an inference from the appearance of a mast with a recorded exposure that can be compared with a stated reference.
The reference levels come from an assessment of health effects. The International Commission on Non-Ionizing Radiation Protection publishes exposure guidelines. Its 2020 document covers a broad radiofrequency range and explains its rationale and limits. It is a scientific recommendation used by authorities, rather than a single law that governs every country automatically.
Questions about the selection of evidence, expert relationships and revision of limits are legitimate. They can be pursued through published methods, disclosures and competing findings. Saying that a guideline is imperfect does not tell us the dose received beside a particular mast or establish which disease it caused.
In May 2011, the International Agency for Research on Cancer classified radiofrequency electromagnetic fields as possibly carcinogenic to humans, Group 2B. The contemporary release describes limited evidence concerning glioma, a brain cancer, and acoustic neuroma, a nonmalignant tumor, among wireless-phone users. “Limited” meant that a causal interpretation was credible, while chance, bias or confounding could not be ruled out.
The classification concerned a possible cancer hazard. It was not a finding that a particular exposure beside a phone mast causes cancer, and it preceded widespread 5G deployment. It also preceded the major 2018 animal results often cited alongside it. Later studies cannot be the basis of an earlier classification.
The US National Toxicology Program's studies exposed rats and mice to radiofrequency signals of the kinds used for 2G and 3G communications. The program's account of its findings reports clear evidence of an association with malignant heart schwannomas—tumors of nerve-supporting cells—in male rats, and some evidence concerning malignant brain gliomas and adrenal tumors in male rats. Findings in female rats and in mice were considered equivocal, not proof that exposure could have no effect in those animals.
The animals received whole-body exposures at levels and durations different from ordinary phone use. A human holding a handset receives a more localized exposure. The experiments used older communications formats. Estimating human risk from them requires accounting for exposure pattern, intensity and duration, as well as the change in technology.
A 2025 animal-study review by Meike Mevissen and colleagues rated the evidence for increased glioma and heart schwannoma risk in male rats as high certainty. The authors did not pool all the studies into one effect estimate because their designs and exposures differed substantially. A 2026 correction addressed extraction and reporting errors and a dose calculation; the authors stated that the overall conclusions were unchanged. The review's confidence judgment concerns the animal evidence. It is not a new IARC classification or a measured risk for people living near 5G masts.
Human research asks a related question under less controlled conditions. In the 2024 COSMOS study, researchers followed 264,574 participants through cancer registries after collecting information about their mobile-phone use. Operator-recorded information helped calibrate reported call time. Over a median follow-up of about seven years, the study found no association between cumulative call time and glioma, meningioma or acoustic neuroma. The researchers recorded 149 gliomas during follow-up. The result therefore does not mean that nobody developed a tumor: it concerns whether risk rose with estimated cumulative call time.
Gathering exposure information before a diagnosis reduces one problem with asking patients to reconstruct their phone use after learning they have a tumor. It does not eliminate errors in recalled earlier use, nor does seven years of follow-up settle every possible latency. Rare outcomes also leave uncertainty around subgroup estimates. Participants were recruited in 2007–2012, so the phone-use history largely concerned older technologies. This was not a decades-long study of 5G.
A 2024 systematic review led by Ken Karipidis brought together 63 human observational articles and found no increased risk for the most researched tumors associated with mobile-phone use. Its scope was specified cancer outcomes, with the strengths and limits of observational exposure assessment. It did not test whether wireless signals create respiratory viruses or establish that every possible effect at every frequency had been excluded.
Animal findings and human studies therefore have to be interpreted together. Controlled exposures can reveal a hazard worth pursuing, while population studies investigate whether a corresponding pattern occurs under human conditions. Neither design becomes irrelevant because the other asks a different version of the question.
People who attribute headaches, fatigue or other symptoms to electromagnetic fields deserve to have the symptoms taken seriously. Accepting the report of distress and accepting its proposed cause are separate judgments.
One way to investigate an immediate exposure effect is to vary the signal without telling participants when it is present. A sham condition preserves the procedure while omitting the test signal; double blinding also keeps the assessor unaware of the assigned condition. This prevents knowledge of the setting from changing alongside the exposure being tested. In a 2007 study, Stacy Eltiti and colleagues tested self-identified sensitive participants and controls under open and double-blind conditions using base-station-like signals in two older mobile formats, GSM and UMTS, and a sham condition. Some participants withdrew after the first open session; the blinded results concern those who continued.
When participants knew about the exposures, sensitive participants reported lower well-being during the active signals. Under blinded testing, the GSM signal produced no detected effect in either group. An arousal difference during the UMTS condition was, on further analysis, more consistent with the order of testing than with exposure; symptom number and severity did not increase, and physiological measures did not differ across exposure conditions.
The study addressed a short-term response to those signals. It did not test decades of exposure, diagnose every participant's symptoms or establish that no one could become ill for another reason. Blinding helped separate the presence of the field from knowledge that it might be present. That is a useful causal test precisely because expectation and exposure are ordinarily difficult to disentangle.
The experiment tests an explanation for symptoms; it does not disqualify the person reporting them.
The 2020 episode also needs accurate evidence about communication and harm. In parliamentary evidence, Mobile UK reported 133 arson attacks on masts and mobile equipment and more than 300 incidents of abuse against telecommunications staff between April and August 2020. These are industry-reported incidents, not 133 independently adjudicated cases proving the same motive. The account includes damage to equipment without 5G and disruption to connectivity serving a Nightingale hospital.
An online discussion count is a different measure again. Wasim Ahmed and colleagues examined Twitter discussion using the #5GCoronavirus hashtag. In a coded sample of 233 tweets, 81 linked 5G and COVID-19, 75 rejected the claim and 77 expressed no personal view. A hashtag's visibility included criticism and other discussion as well as endorsement. Those selected tweets were not a representative survey of what the population believed.
On ITV's This Morning on 13 April 2020, Eamonn Holmes questioned the dismissal of a 5G–COVID connection while also warning against attacks. Ofcom considered his intervention potentially harmful and took account of the surrounding discussion and his clarification the next day. Its published assessment records 755 complaints and concludes that the program did not warrant investigation. It issued guidance to ITV. That outcome is different from a formal finding that this broadcast breached the rules.
Ofcom criticized the intervention while finding that the discussion and subsequent clarification provided adequate protection for viewers.
The case against the 5G–COVID claim rests on the virus, the mechanism of transmission and the lack of the evidence the claim requires. Research into long-term radiofrequency exposure remains a task for defined experiments and carefully interpreted human data. Uncertainty about a long-term exposure effect cannot turn a mast into the source of an infection. Damaging the mast can, however, remove a working connection from the people trying to respond to one.